![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Lipton S.A. Brenneman D.E. Silverstein F.S. Masliah E. Mucke L.
Publisher: Elsevier
ISSN: 0165-6147
Source: Trends in Pharmacological Sciences, Vol.16, Iss.4, 1995-04, pp. : 122-122
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Potent and broadly neutralizing antibodies targeting HIV envelope protein gp120
By Song Min
Future Virology, Vol. 7, Iss. 3, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Conformational Properties of HIV-1 gp120/V3 Immunogenic Domains
Current Medicinal Chemistry, Vol. 12, Iss. 13, 2005-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The GP120 Molecule of HIV-1 and its Interaction with T Cells
Current Medicinal Chemistry, Vol. 17, Iss. 8, 2010-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HIV-1 gp120: A Target for Therapeutics and Vaccine Design
Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. :